{"title": "Treatment Protocol", "author": null, "url": "https://vladimirzelenkomd.com/treatment-protocol/", "hostname": "vladimirzelenkomd.com", "description": null, "sitename": "Dr. Vladimir Zelenko MD", "date": "2021-01-26", "cleaned_text": "Fundamental Principles Treat patients based on clinical suspicion as soon as possible, preferably within the first 5 days of symptoms. Perform PCR testing, but do not withhold treatment pending results. Risk Stratify Patients - Low risk patient - Younger than 45, no comorbidities, and clinically stable - High risk patient - Older than 45, younger than 45 with comorbidities, or clinically unstable Treatment Options Low risk patients - Supportive care with fluids, fever control, and rest - Elemental Zinc 50mg 1 time a day for 7 days - Vitamin C 1000mg 1 time a day for 7 days - Vitamin D3 5000iu 1 time a day for 7 days Optional over the counter options - Quercetin 500mg 2 times a day for 7 days or - Epigallocatechin-gallate (EGCG) 400mg 1 time a day for 7 days Moderate / High risk patients - Elemental Zinc 50-100mg once a day for 7 days - Vitamin C 1000mg 1 time a day for 7 days - Vitamin D3 10000iu once a day for 7 days or 50000iu once a day for 1-2 days - Azithromycin 500mg 1 time a day for 5 days or - Doxycycline 100mg 2 times a day for 7 days - Hydroxychloroquine (HCQ) 200mg 2 times a day for 5-7 days and/or - Ivermectin 0.4-0.5mg/kg/day for 5-7 days Either or both HCQ and IVM can be used, and if one only, the second agent may be added after about 2 days of treatment if obvious recovery has not yet been observed etc. Treatment Options - Dexamethasone 6-12mg 1 time a day for 7 days or - Prednisone 20mg twice a day for 7 days, taper as needed - Budesonide 1mg/2cc solution via nebulizer twice a day for 7 days - Blood thinners Lovenox, Eliquis, Xarelto, Pradaxa, day for 5-7 days - Monoclonal antibodies - Home IV fluids and oxygen TRY TO KEEP PATIENTS OUT OF THE HOSPITAL - https://www.sciencedirect.com/science/article/pii/S0924857920304258 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365891/ - https://pubs.acs.org/doi/10.1021/jf5014633 - https://vdmeta.com/ "}